Nicolas Glaichenhaus Selected Research

Nicolas Glaichenhaus Research Topics

Disease

8	Inflammation (Inflammations) 12/2020 - 02/2002
4	Infections 12/2022 - 07/2009
4	Neoplasms (Cancer) 01/2019 - 04/2005
3	Asthma (Bronchial Asthma) 06/2014 - 02/2008
2	COVID-19 12/2022 - 11/2021
2	Psychotic Disorders (Schizoaffective Disorder) 07/2022 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2003 - 02/2002
1	Neoplasm Metastasis (Metastasis) 02/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Alcoholism (Alcohol Abuse) 07/2022
1	Muscle Weakness 01/2022
1	Facioscapulohumeral Muscular Dystrophy 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2021
1	Major Depressive Disorder (Major Depressive Disorders) 05/2021
1	Necrosis 12/2020
1	Shock 12/2020
1	Fragile X Syndrome (Martin Bell Syndrome) 04/2020
1	Birth Weight (Birth Weights) 03/2020
1	Autistic Disorder (Autism) 01/2020
1	Rheumatoid Arthritis 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2019
1	Septic Shock (Toxic Shock Syndrome) 12/2017
1	Disease Progression 01/2017
1	Atopic Dermatitis (Atopic Eczema) 06/2014
1	Communicable Diseases (Infectious Diseases) 03/2011
1	B-Cell Leukemia (Leukemia, B Cell) 11/2010
1	Lymphoma (Lymphomas) 11/2010
1	Lung Diseases (Lung Disease) 11/2010
1	Airway Obstruction (Choking) 02/2008
1	Chronic Disease (Chronic Diseases) 02/2008
1	Melanoma (Melanoma, Malignant) 04/2005
1	Visceral Leishmaniasis (Kala Azar) 10/2003
1	Myasthenia Gravis 09/2003

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2023 - 01/2017
7	AntigensIBA 06/2011 - 02/2002
4	Peptides (Polypeptides)IBA 07/2005 - 09/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	CorticosteroneIBA 02/2023 - 12/2020
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2023 - 12/2020
2	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2019
2	VaccinesIBA 12/2022 - 04/2005
2	Polytetrafluoroethylene (Teflon)FDA Link 07/2022 - 01/2019
2	ChemokinesIBA 04/2020 - 06/2014
2	AllergensIBA 11/2010 - 02/2008
2	Receptors for Activated C KinaseIBA 07/2005 - 10/2003
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2023
1	Celecoxib (Celebrex)FDA Link 01/2023
1	COVID-19 VaccinesIBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	BNT162 VaccineIBA 12/2022
1	Antidepressive Agents (Antidepressants)IBA 07/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 07/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	LipidsIBA 01/2022
1	Inflammation MediatorsIBA 01/2022
1	mRNA VaccinesIBA 11/2021
1	LipopolysaccharidesIBA 12/2020
1	GlucocorticoidsIBA 12/2020
1	Mifepristone (RU 486)FDA Link 12/2020
1	LeptinIBA 03/2020
1	SilverIBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	EndotoxinsIBA 12/2017
1	Chemokine ReceptorsIBA 06/2014
1	Chemokine CX3CL1IBA 06/2014
1	Interleukin-12 (IL 12)IBA 03/2011
1	Interleukin-4 (Interleukin 4)IBA 03/2011
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 11/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2010
1	EnzymesIBA 08/2010
1	HLA-DPw4 antigenIBA 04/2005
1	Coloring Agents (Dyes)IBA 04/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2005
1	Insulin (Novolin)FDA Link 11/2003
1	Monoclonal AntibodiesIBA 10/2003
1	Leishmania LACK antigenIBA 02/2002
1	AerosolsIBA 02/2002

Therapy/Procedure

1	Injections 12/2022
1	Precision Medicine 07/2022
1	Vagus Nerve Stimulation 12/2019
1	Therapeutics 11/2003